Analysts on average had expected a profit of Rs827 crore, according to Thomson Reuters data. Photo: MintIndia’s largest drugmaker, Sun Pharmaceutical Industries Ltd, posted a 59% plunge in second-quarter profit on Tuesday, but beat estimates. Profit came in at Rs912 crore in the quarter ended 30 September, compared with Rs2,235 crore a year ago, the company said. Analysts on average had expected a profit of Rs827 crore, according to Thomson Reuters data.

Source: Mint November 14, 2017 10:52 UTC